In our comprehensive study involving patients with renal cell carcinoma (RCC), we conducted an in-depth assessment of the roles played by dihydrolipoamide branched chain transacylase E2 (DBT) and genes associated with cuproptosis. This evidence concerns the gene DBT and renal cell adenocarcinoma.